
Uppsala Reports editor
@UMCGlobalSafety
Research / 04 July 2022
Jean Marie Vianney Habarugira and Albert Figueras are all for using pharmacovigilance databases for AMR surveillance. Hear them out on the latest episode of Drug Safety Matters.
Managing antimicrobial resistance (AMR) will require innovative solutions from many different disciplines. Could pharmacovigilance be one of them?
In the latest episode of Drug Safety Matters, Jean Marie Vianney Habarugira and Albert Figueras, who have been investigating how drug safety tools could help track AMR, tell podcast host Federica Santoro why they think it’s time the two communities joined forces for good.
Subscribe by visiting the Drug Safety Matters website or listen in right here:
Duplicate reports are a big problem when it comes to signal detection, but with the help of machine learning and new ways of comparing reports, we may more effectively detect them.
25 April 2024
AI holds potential to transform pharmacovigilance. But navigating the risks requires critical assessment. This article explores AI's evolving role in medicines safety.
22 October 2024
The Research corner film series puts UMC pharmacovigilance scientists in the spotlight as they discuss their research and its implications for pharmacovigilance science.
15 November 2023